Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 06:12 am Unchanged |
2025-04-09 | 13D | SINOVAC BIOTECH LTD SVA |
Advantech Capital L.P. | 5,851,423 8.140% |
0 (Unchanged) |
Filing History |
| 2025-03-25 10:48 am Unchanged |
2025-03-18 | 13D | SINOVAC BIOTECH LTD SVA |
Advantech Capital L.P. | 5,851,423 8.140% |
0 (Unchanged) |
Filing History |
| 2025-03-21 7:16 pm Purchase |
2025-03-18 | 13D | SINOVAC BIOTECH LTD SVA |
WEIDONG YIN | 6,359,500 8.850% |
235,000 (+3.84%) |
Filing History |
| 2025-03-19 3:00 pm Purchase |
2025-03-17 | 13D | SINOVAC BIOTECH LTD SVA |
Vivo Capital IX, LLC | 4,539,456 6.300% |
4,539,456 (New Position) |
Filing History |
| 2025-03-19 06:15 am Unchanged |
2025-03-18 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.000% |
0 (Unchanged) |
Filing History |
| 2025-02-19 4:01 pm Unchanged |
2025-02-18 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.000% |
0 (Unchanged) |
Filing History |
| 2024-09-12 4:03 pm Unchanged |
2024-09-12 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.000% |
0 (Unchanged) |
Filing History |
| 2024-06-17 4:02 pm Unchanged |
2024-06-13 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.030% |
0 (Unchanged) |
Filing History |
| 2024-03-20 07:33 am Sale |
2023-12-31 | 13G | SINOVAC BIOTECH LTD SVA |
Advantech Capital L.P. | 5,851,423 8.160% |
-48,577 (-0.82%) |
Filing History |
| 2023-12-04 06:01 am Unchanged |
2023-12-01 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.030% |
0 (Unchanged) |
Filing History |
| 2023-09-15 08:59 am Unchanged |
2023-09-15 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.030% |
0 (Unchanged) |
Filing History |
| 2023-05-25 07:13 am Unchanged |
2023-05-25 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.030% |
0 (Unchanged) |
Filing History |
| 2023-03-15 06:01 am Unchanged |
2023-03-15 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.030% |
0 (Unchanged) |
Filing History |
| 2022-12-12 06:44 am Unchanged |
2022-11-23 | 13D | SINOVAC BIOTECH LTD SVA |
SAIF Partners IV L.P. | 10,780,820 15.030% |
0 (Unchanged) |
Filing History |
| 2020-12-22 09:25 am Purchase |
2020-12-22 | 13D | SINOVAC BIOTECH LTD SVA |
CDH Fund VI L.P. | 6,000,000 8.440% |
6,000,000 (New Position) |
Filing History |
| 2020-12-18 8:53 pm Purchase |
2020-12-18 | 13D | SINOVAC BIOTECH LTD SVA |
1Globe Capital LLC | 18,515,315 32.300% |
9,162,223 (+97.96%) |
Filing History |